# Mitochondrial integrity modulates mTOR signaling and podocyte function

**Authors:** Cem Özel, Khawla Abualia, Duc Nguyen-Minh, Mahsa Matin, David Unnersjö-Jess, Martin Höhne, Wilhelm Bloch, Henning Hagmann, Richard J.M. Coward, Sebastian Brähler, Bernhard Schermer, Thomas Benzing, Philipp Antczak, Paul T. Brinkkötter

PMC · DOI: 10.1016/j.isci.2025.114279 · iScience · 2025-12-05

## TL;DR

Mitochondrial health affects kidney cell function and disease, with OMA1 playing a key role in regulating this process.

## Contribution

The study reveals that OMA1 ablation rescues glomerular disease in PHB2-deficient mice.

## Key findings

- OMA1 ablation rescues glomerular disease in PHB2-deficient mice.
- Mitochondrial dysfunction sensitizes podocytes to insulin, triggering mTOR overactivation.
- mTOR hyperactivity alone does not drive glomerular disease.

## Abstract

Mitochondrial dysfunction has emerged as a key contributor to the pathogenesis of steroid-resistant nephrotic syndrome (SRNS) and genetic focal-segmental glomerulosclerosis (FSGS). This study explores the role of mitochondrial integrity in podocyte biology, focusing on the impact of OMA1, a critical regulator of mitochondrial morphology. Using a model of disrupted mitochondrial homeostasis, we show that mitochondrial dysfunction sensitizes podocytes to insulin, triggering the overactivation of mTOR signaling. Disruption of OMA1 function was achieved through the deletion of Oma1 or a podocyte-specific knockout of its regulator Phb2. Remarkably, simultaneous Oma1 deletion extended the lifespan of severely affected Phb2pko mice, alleviated proteinuria, and restored mitochondrial morphology. Increased mTOR activity was observed in Phb2pko, Oma1del, and Phb2/Oma1 double-knockout mice. Our findings highlight the critical role of mitochondrial integrity in podocyte function and disease mitigation, providing potential therapeutic insights for mitochondrial dysfunction-associated nephropathies.

•Oma1 ablation rescues glomerular disease in PHB2-deficient mice•Disruption of mitochondrial dynamics sensitizes podocytes to insulin•mTOR hyperactivity alone does not drive glomerular disease

Oma1 ablation rescues glomerular disease in PHB2-deficient mice

Disruption of mitochondrial dynamics sensitizes podocytes to insulin

mTOR hyperactivity alone does not drive glomerular disease

Cell biology

## Linked entities

- **Genes:** OMA1 (OMA1 zinc metallopeptidase) [NCBI Gene 115209], PHB2 (prohibitin 2) [NCBI Gene 11331]
- **Diseases:** steroid-resistant nephrotic syndrome (MONDO:0044765), focal-segmental glomerulosclerosis (MONDO:0100313)

## Full-text entities

- **Genes:** Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Oma1 (OMA1 zinc metallopeptidase) [NCBI Gene 67013] {aka 2010001O09Rik, MPRP-1, ZMPOMA1}, Phb2 (prohibitin 2) [NCBI Gene 12034] {aka BAP, Bap37, Bcap37, REA}
- **Diseases:** proteinuria (MESH:D011507), FSGS (MESH:D005923), nephropathies (MESH:D007674), Mitochondrial dysfunction (MESH:D028361), steroid (MESH:D016114), SRNS (MESH:D009404)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12774701/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12774701/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12774701/full.md

---
Source: https://tomesphere.com/paper/PMC12774701